statistiche ricercatore

Continente	#
NA - Nord America	1.688
EU - Europa	908
AS - Asia	633
SA - Sud America	101
AF - Africa	15
Continente sconosciuto - Info sul continente non disponibili	1
Totale	3.346

Nazione	#
US - Stati Uniti d'America	1.652
DE - Germania	309
SG - Singapore	292
IT - Italia	182
CN - Cina	141
RU - Federazione Russa	96
BR - Brasile	80
HK - Hong Kong	79
SE - Svezia	75
IE - Irlanda	71
GB - Regno Unito	47
VN - Vietnam	44
UA - Ucraina	42
CA - Canada	31
TR - Turchia	20
FI - Finlandia	19
BE - Belgio	17
FR - Francia	12
IN - India	9
NL - Olanda	9
ID - Indonesia	8
JP - Giappone	8
DK - Danimarca	7
AR - Argentina	6
PK - Pakistan	6
ZA - Sudafrica	6
IQ - Iraq	5
EC - Ecuador	4
MA - Marocco	4
PL - Polonia	4
VE - Venezuela	4
AT - Austria	3
CO - Colombia	3
RO - Romania	3
SA - Arabia Saudita	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
AZ - Azerbaigian	2
BD - Bangladesh	2
BG - Bulgaria	2
HN - Honduras	2
KG - Kirghizistan	2
LB - Libano	2
LT - Lituania	2
PT - Portogallo	2
UZ - Uzbekistan	2
AM - Armenia	1
CL - Cile	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
GA - Gabon	1
GR - Grecia	1
GT - Guatemala	1
KW - Kuwait	1
KZ - Kazakistan	1
MY - Malesia	1
NI - Nicaragua	1
NO - Norvegia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PY - Paraguay	1
SN - Senegal	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.346

Nome	#
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study	459
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study	404
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates	400
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years	381
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis	365
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation	255
Myb-Binding Protein 1A (MYBBP1A) Is Essential for Early Embryonic Development, Controls Cell Cycle and Mitosis, and Acts as a Tumor Suppressor	250
Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition	245
p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity	235
Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism	227
Branch migration displacement assay with automated heuristic analysis for discrete DNA length measurement using DNA microarrays	221
Totale	3.442

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	256	0	0	0	0	0	0	33	52	46	48	44	33
2021/2022	230	25	31	33	20	7	10	6	11	7	11	32	37
2022/2023	534	25	108	81	77	69	84	3	24	19	8	8	28
2023/2024	235	16	16	10	16	39	49	44	2	12	5	1	25
2024/2025	452	19	28	23	28	50	26	25	11	69	63	49	61
2025/2026	604	136	33	70	116	152	88	9	0	0	0	0	0
Totale													3.442

Bicocca Open Archive